By: Tracie Carter
A Florida man with ties to a North Jersey pharmacy operation has been sentenced for his role in a massive health care fraud and kickback scheme, according to information released by federal authorities.
On April 1, 2026, Adam Brosius, 61, of Delray Beach, was sentenced to 24 months in prison following his conviction in a $33 million fraud case, U.S. Attorney Robert Frazer announced.
According to documents filed in the case and statements made in court, Brosius played a key leadership role at Main Avenue Pharmacy, a mail-order pharmacy that operated with a storefront in Clifton, New Jersey.
Between 2014 and 2016, authorities say the pharmacy was at the center of an illegal operation involving medically unnecessary compounded medications, including creams for pain, scars, and migraines, along with vitamins.
Investigators determined that Brosius, who served as the pharmacy’s director of business development and later as its president, helped orchestrate a system designed to maximize insurance reimbursements.
The pharmacy identified high-profit compounded drug formulas and distributed pre-printed prescription pads featuring those medications to marketing companies nationwide.
Those marketers then worked with telemedicine providers and doctors who, in some cases, had financial arrangements tied to the prescriptions.
Once prescriptions were issued and filled, Main Avenue Pharmacy billed health care benefit programs—including Medicare, TRICARE, and private insurers—often for drugs that were not medically necessary.
After receiving payments, the pharmacy funneled kickbacks to marketers based on the number of prescriptions generated and the reimbursement amounts collected.
Authorities said the operation resulted in approximately $33 million in reimbursements, including more than $5.8 million paid through TRICARE, a federal health care program.
As part of his sentence, U.S. District Judge Madeline Cox Arleo ordered Brosius to pay $33 million in restitution and forfeit $27 million. 
He will also serve a term of supervised release following his prison sentence.
Federal officials say the case highlights ongoing efforts to crack down on health care fraud schemes that exploit both public and private insurance systems.